{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T10:21:29Z","timestamp":1784802089895,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-19515-4","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:50:19Z","timestamp":1760363419000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular signals associated with intraperitoneal chemotherapy resistance in gastric cancer with peritoneal metastasis through PIPS GC trial integrated translational research"],"prefix":"10.1038","volume":"15","author":[{"given":"Won Jun","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"19515_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"19515_CR2","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.3390\/jcm10214882","volume":"10","author":"A Rijken","year":"2021","unstructured":"Rijken, A. et al. The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival. J. Clin. Med. 10, 4882 (2021).","journal-title":"J. Clin. Med."},{"key":"19515_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10120-017-0738-1","volume":"21","author":"K Yamaguchi","year":"2018","unstructured":"Yamaguchi, K. et al. The long-term survival of stage IV gastric cancer patients with conversion therapy. Gastric Cancer. 21, 315\u2013323 (2018).","journal-title":"Gastric Cancer"},{"key":"19515_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5230\/jgc.2023.23.e11","volume":"23","author":"TH Kim","year":"2023","unstructured":"Kim, T. H. et al. Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. J. Gastric Cancer. 23, 3 (2023).","journal-title":"J. Gastric Cancer"},{"key":"19515_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.6004\/jnccn.2013.0070","volume":"11","author":"JA Ajani","year":"2013","unstructured":"Ajani, J. A. et al. Gastric cancer, version 2. 2013: featured updates to the NCCN guidelines. J. Natl. Compr. Canc Netw. 11, 531\u2013546 (2013).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"19515_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","volume":"26","author":"Japanese Gastric Cancer Association","year":"2023","unstructured":"Japanese Gastric Cancer Association Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer. 26, 1\u201325 (2023).","journal-title":"Gastric Cancer"},{"key":"19515_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41571-022-00675-5","volume":"19","author":"V Kepenekian","year":"2022","unstructured":"Kepenekian, V. et al. Advances in the management of peritoneal malignancies. Nat. Rev. Clin. Oncol. 19, 698\u2013718 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"19515_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.5230\/jgc.2021.21.e38","volume":"21","author":"DW Kim","year":"2021","unstructured":"Kim, D. W. et al. Intraperitoneal Paclitaxel combined with S-1 plus oxaliplatin for advanced gastric cancer with peritoneal metastasis: a phase I study. J. Gastric Cancer. 21, 418 (2021).","journal-title":"J. Gastric Cancer"},{"issue":"6","key":"19515_CR9","doi-asserted-by":"publisher","first-page":"109603","DOI":"10.1016\/j.ejso.2025.109603","volume":"51","author":"WJ Seo","year":"2025","unstructured":"Seo, W. J. et al. Intraperitoneal paclitaxel with systemic S-1 Plus oxaliplatin for advanced or recurrent gastric cancer with peritoneal metastasis: a single-arm, multicenter phase II clinical trial. Eur J. Surg. Oncol. 51(6), 109603 (2025).","journal-title":"Eur J. Surg. Oncol."},{"key":"19515_CR10","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","volume":"36","author":"H Ishigami","year":"2018","unstructured":"Ishigami, H. et al. Phase III trial comparing intraperitoneal and intravenous Paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial. J. Clin. Oncol. 36, 1922\u20131929 (2018).","journal-title":"J. Clin. Oncol."},{"key":"19515_CR11","doi-asserted-by":"publisher","first-page":"8597","DOI":"10.1245\/s10434-022-11998-z","volume":"29","author":"DKA Chia","year":"2022","unstructured":"Chia, D. K. A. et al. Outcomes of a phase II study of intraperitoneal Paclitaxel plus systemic capecitabine and oxaliplatin (XELOX) for gastric cancer with peritoneal metastases. Ann. Surg. Oncol. 29, 8597\u20138605 (2022).","journal-title":"Ann. Surg. Oncol."},{"key":"19515_CR12","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.21037\/jgo-2020-03","volume":"12","author":"PH Sugarbaker","year":"2021","unstructured":"Sugarbaker, P. H. Intraperitoneal paclitaxel: pharmacology, clinical results and future prospects. J. Gastrointest. Oncol. 12, S231\u2013S239 (2021).","journal-title":"J. Gastrointest. Oncol."},{"key":"19515_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jss.2008.06.049","volume":"155","author":"D Soma","year":"2009","unstructured":"Soma, D. et al. Different tissue distribution of Paclitaxel with intravenous and intraperitoneal administration. J. Surg. Res. 155, 142\u2013146 (2009).","journal-title":"J. Surg. Res."},{"key":"19515_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/pp-2017-0002","volume":"2","author":"J Kitayama","year":"2017","unstructured":"Kitayama, J. et al. Optimal drug delivery for intraperitoneal Paclitaxel (PTX) in murine model. Pleura Peritoneum. 2, 95\u2013102 (2017).","journal-title":"Pleura Peritoneum"},{"key":"19515_CR15","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.2147\/OTT.S239336","volume":"13","author":"T Ruan","year":"2020","unstructured":"Ruan, T., Liu, W., Tao, K. & Wu, C. A review of research progress in multidrug-resistance mechanisms in gastric cancer. OncoTargets Therapy. 13, 1797\u20131807 (2020).","journal-title":"OncoTargets Therapy"},{"key":"19515_CR16","unstructured":"Chapman, B. et al. bcbio\/bcbio-nextgen: v1.2.3. GitHub (2020). https:\/\/github.com\/bcbio\/bcbio-nextgen"},{"key":"19515_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"19515_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, snpeff: SNPs in the genome of drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6, 80\u201392 (2012).","journal-title":"Fly"},{"key":"19515_CR19","doi-asserted-by":"publisher","first-page":"11101","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera, G. A. et al. From FastQ data to high confidence variant calls: the genome analysis toolkit best practices pipeline. Curr. Protoc. Bioinforma. 43, 11101\u2013111033 (2013).","journal-title":"Curr. Protoc. Bioinforma"},{"key":"19515_CR20","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich, E. et al. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput. Biol. 12, e1004873 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"19515_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.gpb.2020.02.001","volume":"18","author":"P Jia","year":"2020","unstructured":"Jia, P. et al. MSIsensor-pro: fast, accurate, and matched-normal-sample-free detection of microsatellite instability. Genomics Proteom. Bioinf. 18, 65\u201371 (2020).","journal-title":"Genomics Proteom. Bioinf."},{"key":"19515_CR22","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMp1607591","volume":"375","author":"RL Grossman","year":"2016","unstructured":"Grossman, R. L. et al. Toward a shared vision for cancer genomic data. N Engl. J. Med. 375, 1109\u20131112 (2016).","journal-title":"N Engl. J. Med."},{"key":"19515_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"19515_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R. et al. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods. 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"19515_CR25","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson, C. et al. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Research 4, 1521 (2015).","journal-title":"F1000Research"},{"key":"19515_CR26","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"19515_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell. Syst. 1, 417\u2013425 (2015).","journal-title":"Cell. Syst."},{"key":"19515_CR28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"The Cancer Genome Atlas Research Network","year":"2014","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202\u2013209 (2014).","journal-title":"Nature"},{"key":"19515_CR29","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico, A. et al. TCGAbiolinks: an r\/bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71 (2016).","journal-title":"Nucleic Acids Res."},{"key":"19515_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux, R. & Seoighe, C. A flexible R package for nonnegative matrix factorization. BMC Bioinform. 11, 367 (2010).","journal-title":"BMC Bioinform."},{"key":"19515_CR31","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A. et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747\u20131756 (2018).","journal-title":"Genome Res."},{"key":"19515_CR32","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1158\/1078-0432.CCR-21-0792","volume":"27","author":"HY Jeong","year":"2021","unstructured":"Jeong, H. Y. et al. Spatially distinct reprogramming of the tumor microenvironment based on tumor invasion in diffuse-type gastric cancers. Clin. Cancer Res. 27, 6529\u20136542 (2021).","journal-title":"Clin. Cancer Res."},{"key":"19515_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"19515_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13059-021-02584-9","volume":"23","author":"S Choudhary","year":"2022","unstructured":"Choudhary, S. & Satija, R. Comparison and evaluation of statistical error models for scRNA-seq. Genome Biol. 23, 27 (2022).","journal-title":"Genome Biol."},{"key":"19515_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S. et al. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell. Syst. 8, 329\u2013337 (2019).","journal-title":"Cell. Syst."},{"key":"19515_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"19515_CR37","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41467-022-28803-w","volume":"13","author":"A Ianevski","year":"2022","unstructured":"Ianevski, A. et al. Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data. Nat. Commun. 13, 1246 (2022).","journal-title":"Nat. Commun."},{"key":"19515_CR38","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/s41467-023-37353-8","volume":"14","author":"I Nofech-Mozes","year":"2023","unstructured":"Nofech-Mozes, I. et al. Pan-cancer classification of single cells in the tumour microenvironment. Nat. Commun. 14, 1615 (2023).","journal-title":"Nat. Commun."},{"key":"19515_CR39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/genes10070531","volume":"10","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. SCINA: a semi-supervised subtyping algorithm of single cells and bulk samples. Genes 10, 531 (2019).","journal-title":"Genes"},{"key":"19515_CR40","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using cellchat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"19515_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res"},{"key":"19515_CR42","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1158\/2159-8290.CD-21-0683","volume":"12","author":"V Kumar","year":"2022","unstructured":"Kumar, V. et al. Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 12, 670\u2013691 (2022).","journal-title":"Cancer Discov"},{"key":"19515_CR43","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/cac2.12533","volume":"44","author":"KT Kim","year":"2024","unstructured":"Kim, K. T. et al. Deciphering metastatic route-specific signals and their microenvironment interactions in peritoneal metastasis of gastric cancer. Cancer Commun. 44, 514\u2013517 (2024).","journal-title":"Cancer Commun."},{"key":"19515_CR44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41436-020-00947-4","volume":"23","author":"S Elbitar","year":"2021","unstructured":"Elbitar, S. et al. Pathogenic variants in THSD4, encoding the ADAMTS-like 6 protein, predispose to inherited thoracic aortic aneurysm. Genet. Med. 23, 111\u2013122 (2021).","journal-title":"Genet. Med."},{"key":"19515_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","volume":"22","author":"Z Yuan","year":"2023","unstructured":"Yuan, Z. et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol. Cancer. 22, 48 (2023).","journal-title":"Mol. Cancer"},{"key":"19515_CR46","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1038\/s41467-022-33282-0","volume":"13","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies. Nat. Commun. 13, 5723 (2022).","journal-title":"Nat. Commun."},{"key":"19515_CR47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.yexmp.2018.01.005","volume":"104","author":"K Grupp","year":"2018","unstructured":"Grupp, K. et al. Expression of ICAM-1, E-cadherin, Periostin and midkine in metastases of pancreatic ductal adenocarcinomas. Exp. Mol. Pathol. 104, 109\u2013113 (2018).","journal-title":"Exp. Mol. Pathol."},{"key":"19515_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/CCO.0b013e32835b6371","volume":"25","author":"Y Katsuno","year":"2013","unstructured":"Katsuno, Y. et al. TGF-\u03b2 signaling and epithelial-mesenchymal transition in cancer progression. Curr. Opin. Oncol. 25, 76\u201384 (2013).","journal-title":"Curr. Opin. Oncol."},{"key":"19515_CR49","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s13277-012-0406-3","volume":"33","author":"YY Xu","year":"2012","unstructured":"Xu, Y. Y. et al. Midkine confers adriamycin resistance in human gastric cancer cells. Tumour Biol. 33, 1543\u20131548 (2012).","journal-title":"Tumour Biol."},{"key":"19515_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12185-010-0613-x","volume":"92","author":"R Hu","year":"2010","unstructured":"Hu, R. et al. Increased drug efflux along with midkine gene high expression in childhood B-lineage acute lymphoblastic leukemia cells. Int. J. Hematol. 92, 105\u2013110 (2010).","journal-title":"Int. J. Hematol."},{"key":"19515_CR51","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-020-1073-3","volume":"26","author":"D Cerezo-Wallis","year":"2020","unstructured":"Cerezo-Wallis, D. et al. Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state. Nat. Med. 26, 1865\u20131877 (2020).","journal-title":"Nat. Med."},{"key":"19515_CR52","doi-asserted-by":"crossref","unstructured":"Wan, S. et al. Integrated transcriptomics identifies prognostic significance and therapeutic response of cancer-associated fibroblast subpopulations in ovarian cancer. Aging 205997 (2024).","DOI":"10.18632\/aging.205997"},{"key":"19515_CR53","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s11010-022-04436-x","volume":"477","author":"KD Yang","year":"2022","unstructured":"Yang, K. D. et al. CAF-derived midkine promotes EMT and cisplatin resistance by upregulating LncRNA ST7-AS1 in gastric cancer. Mol. Cell. Biochem. 477, 2493\u20132505 (2022).","journal-title":"Mol. Cell. Biochem."},{"key":"19515_CR54","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ags3.12060","volume":"2","author":"J Kitayama","year":"2018","unstructured":"Kitayama, J. et al. Treatment of patients with peritoneal metastases from gastric cancer. Ann. Gastroenterol. Surg. 2, 116\u2013123 (2018).","journal-title":"Ann. Gastroenterol. Surg."},{"key":"19515_CR55","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","volume":"390","author":"YK Kang","year":"2017","unstructured":"Kang, Y. K. et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390, 2461\u20132471 (2017).","journal-title":"Lancet"},{"key":"19515_CR56","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1470-2045(21)00692-6","volume":"23","author":"YK Kang","year":"2022","unstructured":"Kang, Y. K. et al. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 23, 234\u2013247 (2022).","journal-title":"Lancet Oncol."},{"key":"19515_CR57","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol. Cancer. 22, 159 (2023).","journal-title":"Mol. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19515-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:13:45Z","timestamp":1760368425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19515-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19515"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19515-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Institutional Review Board of Korea University Guro Hospital (2022GR0367), and informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"35682"}}